The A.I. boom could also give a boost to these investing trends. How to play it
CNBC· 4 小時前Breakthroughs in artificial intelligence are making investors see many tech companies in a new ...
US FDA panel says current data not 'convincing' for Biogen's ALS drug
Reuters· 4 日前A panel of advisers to the U.S. health regulator said on Wednesday there was not enough ... ...
Altimmune's obesity drug throws up safety concerns, shares plunge
Reuters· 5 日前Nausea and vomiting were the most common adverse events, with one patient experienced a serious case, ...
US FDA proposes higher bar for accelerated approvals for cancer drugs
Reuters· 2 日前The U.S. health regulator on Friday proposed cancer drug developers in most cases ...
GSK loses bid to keep experts out of upcoming Zantac trial
Reuters· 2 日前A California judge on Thursday denied GSK Plc's (GSK.L) bid to keep expert testimony ... ...
Sanofi, Regeneron unveil 'blow-out' smoker's lung drug data
Reuters· 3 日前Sanofi's (SASY.PA) asthma drug Dupixent met all targets in a trial to treat "smoker ...
Analysis: In US abortion pill case, FDA could soften blow of court-ordered restrictions
Reuters· 3 日前A conservative federal judge in Texas could soon order the U.S. Food and Drug Administration ...
This New Skincare Line Is Changing How We Protect Our Skin From The Sun—And How We Age
Forbes· 4 日前From there, Bai attended the Massachusetts Institute of Technology, where she studied chemical ...
U.S.-China Collaboration Could Cut Development Time, Cost For New Cancer Treatments
Forbes· 4 日前Tension between Washington and Beijing is on the rise over China’s close ties with Russia, ...
Can Cloud Tech Be A Port In The Economic Storm?
Forbes· 3 日前Everybody and their cousin from Happiness, Arizona has been worried about banking and interest ...
